CANNABIS
Adding smoked cannabis to concomitant analgesics reduce medically refractory pain in HIV patients
Neuropsychopharmacology. 2009 February;34(3):672-680. http://dx.doi.org/10.1038/npp.2008.12034 patients with human immunodeficiency virus (HIV) and with neuropathic pain refractory to a least two previous analgesics, were randomly assigned to active or placebo smoked cannabis. The study aimed to examine the effect of cannabis on pain intensity mood and daily functioning compared to placebo. After a week of treatment, pain reduction, measured by the Descriptor Differential Scale, was significantly greater in the cannabis group compared to placebo group. Mood disturbance, physical disability, and quality of life were improved for the cannabis and placebo treatments similarly.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
